ravi

 16- and 17-year-olds are now eligible for a Pfizer/BioNTech Covid-19 vaccine booster...... The US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17, and the US Centers for Disease Control and Prevention recommended it for this age group. It's the first Covid-19 vaccine booster authorized for 16- and 17-year-olds in the United States. Just as with adults, 16- and 17-year-olds are eligible to receive a booster dose six months after their second dose of the Pfizer/BioNTech vaccine. About 2.6 million US teens in this age group would be eligible for boosters already -- a small addition to the 141 million adults already eligible for boosters. "The Pfizer-BioNTech COVID-19 Vaccine has been available to individuals 16 years of age and older for nearly a year, and its benefits have been shown to clearly outweigh potential risks," Dr. Peter Marks, director of the FDA's Center for Biologics Eva...

Biden talks Washington partisanship in first late-night interview as president President Joe Biden lamented hyper-partisanship in Washington in his first late-night interview since taking office, saying that while he used to have a cordial relationship with Republicans, "the Big Lie ... makes it awful hard." Biden appeared on "The Tonight Show" on Friday, telling host Jimmy Fallon that "QAnon and extreme elements of the Republican Party" and former President Donald Trump's continued efforts to challenge the 2020 election results, are challenges to bipartisanship. "Q-Anon and the extreme elements of the Republican Party and what, Donald Trump keeps sort of, seems to me feeding the, you know what, the big lie, it makes it awful hard," Biden said. "For example, one of the reasons I'm a little bit late coming on is because -- not coming on, but to do the taping here, is because I did Bob Dole's eulogy today," the President added...

Star Health shares list at discount. Should you buy, sell or hold? Home / Markets / Stock Markets /  Star Health shares list at discount. Should you buy, sell or hold? Star Health shares list at discount. Should you buy, sell or hold?Star Health share price: Allottees are advised to book loss at current levels and make fresh entry at around ₹725 to ₹750 levels, say stock market experts. Photo: Courtesy Star Health Insurance website1 min read . Updated: 10 Dec 2021, 10:50 AM ISTAsit Manohar Tepid listing of Star Health share was expected as its valuations were around 15 to 20 per cent higher, say stock market experts Listen to this article Shares of Star Health and Allied Insurance Company got listed today on NSE and BSE at near 6 per cent discounted price. Star Health share price made its debut on NSE at ₹845 whereas it opened on BSE at ₹848.8 apiece levels. According to stock market experts, tepid listing was expect...

Granddaughter shares 82-year-old grandma getting 1st tattoo on TikTok It’s never too late to get your first tattoo. https://ift.tt/3CEnyl7